Adam Lightfoot

Dr. Adam Lightfoot

Department of Life Sciences, Faculty of Science & Engineering, Manchester Metropolitan University, Manchester, UK
orcid
Senior Lecturer - Cell & Molecular Physiology

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2018
Verified
Book Chapter
Closed access
PDF file
ATAnastasia Thoma
Anastasia Thoma
ALAdam Lightfoot
Adam Lightfoot

29 September 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GSGiorgos K. Sakellariou
Giorgos K. Sakellariou
TPTimothy Pearson
Timothy Pearson
ALAdam Lightfoot
Adam Lightfoot
GNGareth Nye
Gareth Nye
NWNicola Wells
Nicola Wells
AMAnne McArdle
Anne McArdle
Age-related loss of skeletal muscle mass and function is a major contributor to morbidity and has a profound effect on the quality of life of older people. The potential role of age-dependent mitochondrial dysfunction and cumulative oxidative stress as the underlying cause of muscle aging remains a controversial topic. Here we show that the pharmacological attenuation of age-related mitochondrial redox changes in muscle with SS31 is associated with some improvements in oxidative damage and mitophagy in muscles of old mice. However, this treatment failed to rescue the age-related muscle fiber atrophy associated with muscle atrophy and weakness. Collectively, these data imply that the muscle mitochondrial redox environment is not a key regulator of muscle fiber atrophy during sarcopenia but may play a key role in the decline of mitochondrial organelle integrity that occurs with muscle aging.

1 November 2016 in Current Opinion in Rheumatology
Verified
Journal Article
Closed access
ALAdam Lightfoot
Adam Lightfoot
RCRobert G. Cooper
Robert G. Cooper
Purpose of review: This article updates on the concept that muscle-derived cytokines (myokines) play important roles in muscle health and disease. Recent findings: Interleukin-6 (IL-6) is released from normal skeletal muscle in response to exercise, mediating both anti-inflammatory responses and metabolic adaptations, actions contradictory to the prevailing view that IL-6 is a proinflammatory cytokine that is inducing and propagating disease. The anti-inflammatory effects of IL-6 result from its trans-membrane signalling capability, via membrane-bound receptors, whereas its proinflammatory effects result instead from signalling via the soluble IL-6 receptor and gp130. IL-15 is elevated following exercise, promoting muscle fibre hypertrophy in some circumstances, while inducing fibre apoptosis in others. This functional divergence appears because of variations in expression of IL-15 receptor isoforms. Decorin, a recently described myokine, is also elevated following exercise in normal muscle, and promotes muscle fibre hypertrophy by competitively binding to, and thus inhibiting, myostatin, a negative regulator of muscle protein synthesis. Exercise-induced myostatin downregulation thus promotes muscle fibre growth, prompting recent trials of a biological myostatin inhibitor in inclusion body myositis. Summary: Myokines appear to exert diverse beneficial effects, though their mechanistic roles in myositis and other myopathologies remain poorly understood.

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
AMAyman Mahmoud
Ayman Mahmoud
FWFiona L. Wilkinson
Fiona L. Wilkinson
MSMansur A. Sandhu
Mansur A. Sandhu
ALAdam Lightfoot
Adam Lightfoot
Oxidative stress is caused by the overproduction of Reactive Oxygen Species (ROS) and diminished cellular antioxidant defenses. Under physiological conditions, ROS are involved in processes, including cellular homeostasis, modulation of cellular metabolism, signaling and redox state, and being used by the immune system to inactivate viruses and inhibit bacterial growth. However, excess ROS production can damage lipids, DNA, and proteins, which can lead to cell death. ROS-induced damage underpins various oxidative stress-related human diseases and aging. In addition, cellular antioxidant defenses may decrease during aging, resulting in age-related increase in ROS and oxidative stress. Excess ROS can also activate proinflammatory signaling pathways and the release of multiple inflammatory mediators, such as cytokines, chemokines, eicosanoids, and others. Therefore, oxidative stress is implicated in the pathogenesis, development, and progression of a sustained inflammatory state. Furthermore, excess ROS and inflammation work together to trigger and orchestrate necrotic and apoptotic cell death, where mitochondrial dysfunction, caspase activation, and Bcl-2 family proteins are involved in ROS-mediated apoptosis. In addition, several protein kinases and signaling pathways (including mitogen-activated protein kinases, nuclear factor-kappaB, protein kinase C, and others) modulate apoptosis depending on the cellular context.

1 July 2015 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
ALAdam Lightfoot
Adam Lightfoot
AMAnne McArdle
Anne McArdle
MJMalcolm Jackson
Malcolm Jackson
RCRobert G Cooper
Robert G Cooper
The idiopathic inflammatory myopathies (IIMs) are a group of rare autoimmune disorders, collectively known as myositis. Affected patients present with proximal muscle weakness, which usually improves following treatment with immunosuppressants, but often incompletely so, thus many patients remain weak. IIMs are characterised histologically by inflammatory cell infiltrates into skeletal muscle and overexpression of major histocompatibility complex I on muscle cell surfaces. Although inflammatory cell infiltrates represent a major feature of myositis there is growing evidence that muscle weakness correlates only poorly with the degree of cellular infiltration, while weakness may in fact precede such infiltrations. The mechanisms underpinning such non-immune cell mediated weakness in IIM are poorly understood. Activation of the endoplasmic reticulum stress pathways appears to be a potential contributor. Data from non-muscle cells indicate that endoplasmic reticulum stress results in altered redox homeostasis capable of causing oxidative damage. In myopathological situations other than IIM, as seen in ageing and sepsis, evidence supports an important role for reactive oxygen species (ROS). Modified ROS generation is associated with mitochondrial dysfunction, depressed force generation and activation of muscle catabolic and autophagy pathways. Despite the growing evidence demonstrating a key role for ROS in skeletal muscle dysfunction in myopathologies other than IIM, no research has yet investigated the role of modified generation of ROS in inducing the weakness characteristic of IIM. This article reviews current knowledge regarding muscle weakness in the absence of immune cells in IIM, and provides a background to the potential role of modified ROS generation as a mechanism of muscle dysfunction. The authors suggest that ROS-mediated mechanisms are potentially involved in non-immune cell mediated weakness seen in IIM and outline how these mechanisms might be investigated in this context. This appears a timely strategy, given recent developments in targeted therapies which specifically modify ROS generation.

1 October 2009 in Critical Care Medicine
Verified
Journal Article
Closed access
ALAdam Lightfoot
Adam Lightfoot
AMAnne McArdle
Anne McArdle
RGRichard D. Griffiths
Richard D. Griffiths
The physical inactivity of the critically ill patient is an abnormal state that compromises muscle function to an extent that the immobile skeletal muscle may not simply be a bystander in the disease process.Skeletal muscle seems to maintain a system of defense against inflammation through heat shock proteins and the production of myokines. It contributes in a bidirectional role in systemic inflammatory signaling and the modulation of the inflammatory response. Skeletal muscle is a major contributor to whole-body glucose and protein metabolism, exemplified by its role in nutrient provision for the immune system and other rapidly dividing tissues through glutamine production.